Physician profile

William L Todd

Acute Care (Nurse Practitioner) · Augusta, GA

NPI 1265832042

$312.78

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

See the full distribution for Acute Care (Nurse Practitioner)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$118.46

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ucb, INC. $100.79 2021-2023 Briviact
Bioventus LLC $98.46 2021
Alexion Pharmaceuticals, INC. $40.07 2023-2024 Soliris, Ultomiris
Sk Life Science, INC. $28.76 2024
Neurelis, INC. $19.90 2024 Valtoco
Octapharma USA, INC. $13.75 2024 Panzyga
Natus Medical Incorporated $11.05 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

William L Todd

$312.78

in general payments reported 2019-2025

Years
2021-2024
Top company
Ucb, INC.

https://glasscript.com/doctor/11178510/william-l-todd

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.